NCT00049361View on ClinicalTrials.gov

Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 1, 2004

Primary Completion Date

December 7, 2004

Study Completion Date

December 7, 2004

Conditions

Brain and Central Nervous System TumorsUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

temozolomide

DRUG

thalidomide

RADIATION

radiation therapy

Trial Locations (5)

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

62526

CCOP - Central Illinois, Decatur

27534-9479

CCOP - Southeast Cancer Control Consortium, Goldsboro

27157-1030

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00049361 - Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases | Biotech Hunter | Biotech Hunter